VTGN vs MTNB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VTGN Captures Institutional Edge (2โ1 Pillars ยท 3โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vistagen Therapeutics, Inc. Common Stock (VTGN) driven by superior Growth & Margin, Options & Structure while MTNB counters with relative strength in Momentum & Technical. Fundamentally, VTGN trades at N/M Forward P/E with -2543.1% operating margin (-46.5% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, VTGN sits in UNCLASSIFIED (71st %ile IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VTGN Revenue | MTNB Revenue | VTGN Op. Margin | MTNB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | N/A | $0M | N/A | -21067.4% | MTNB |
| FY2020 | N/A | $0M | N/A | -15288.4% | MTNB |
| FY2021 | $0M | $0M | -1646.1% | -74954.5% | VTGN |
| FY2022 | $0M | $0M | -4308.3% | -771.3% | MTNB |
| FY2023 | N/A | $0M | N/A | -2168.4% | MTNB |
| FY2024 | $0M | N/A | -3103.5% | N/A | VTGN |
| FY2025 | $0M | N/A | -11517.1% | N/A | VTGN |
| FY2026 | $0M | N/A | -5683.7% | N/A | VTGN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VTGN | MTNB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $9.0M | $979,904 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -46.5% | -100.0% | Higher Growth | VTGN |
| Operating Margin (TTM) Profitability | -2543.1% | 0.0% | Higher Margin | MTNB |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -144.9% | -147.5% | Higher ROE | VTGN |
| 52-Week Range Position Momentum | 0% ($0โ$5) | 22% ($0โ$3) | Stronger Trend | MTNB |
| Beta / 30D Volatility Risk Regime | 1.23ฮฒ ยท 80% Vol | -7.20ฮฒ ยท 147% Vol | Lower Realized Risk | VTGN |
| Unified Institutional Score Composite Signal | 42.3 / 100 (HOLD) | 54.6 / 100 (HOLD) | Higher Composite | MTNB |